Personalized Medicine Staff Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health U.S. Food and Drug AdministrationBiography
Adam C. Berger, Ph.D. is a Senior Staff Fellow in the Office of In Vitro Diagnostics and Radiological Health at the U.S. Food and Drug Administration (FDA). In his role as part of the personalized medicine staff, Dr. Berger addresses a wide range of policy and regulatory issues from precision medicine to digital health. Dr. Berger recently returned to FDA after serving as a Senior Fellow to the Secretary of Health and Human Services. In this role, he oversaw the development and implementation of the President's Precision Medicine Initiative (PMI) across all operating and staff divisions of the Department of Health and Human Services, including all activities at the National Institutes of Health (NIH), FDA, Office of the National Coordinator for Health IT, and the Office for Civil Rights. Dr. Berger also served as the main liaison between and representative of HHS to other United States Government Departments involved in the PMI and the White House. Prior to working in government, he was a Senior Program Officer and Director of the Roundtable on Translating Genomic-Based Research for Health in the Board on Health Sciences Policy at the Institute of Medicine (IOM). Dr. Berger's primary policy roles at the IOM focused on translational medicine, including the development of drug, diagnostic, and clinical and public health applications for genomic and regenerative medicine technologies. Dr. Berger received his doctorate from Emory University in the Biochemistry, Cell and Developmental Biology Program, his B.S. in Molecular Genetics from The Ohio State University, and completed his postdoctoral training at the National Cancer Institute of the National Institutes of Health (NIH). He is the recipient of the NIH Fellows Award for Research Excellence and a Ruth L. Kirschstein National Research Service Award.